These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 7849488)
41. Intimal hyperplasia after vascular injury is inhibited by antisense cdk 2 kinase oligonucleotides. Morishita R; Gibbons GH; Ellison KE; Nakajima M; von der Leyen H; Zhang L; Kaneda Y; Ogihara T; Dzau VJ J Clin Invest; 1994 Apr; 93(4):1458-64. PubMed ID: 8163650 [TBL] [Abstract][Full Text] [Related]
42. Differential regulation of fyn-associated protein tyrosine kinase activity by macrophage colony-stimulating factor (M-CSF) and granulocyte-macrophage colony-stimulating factor (GM-CSF). Li Y; Chen B J Leukoc Biol; 1995 Mar; 57(3):484-90. PubMed ID: 7884321 [TBL] [Abstract][Full Text] [Related]
43. Inhibition of HIV-1 in vitro by C-5 propyne phosphorothioate antisense to rev. Lund OS; Nielsen JO; Hansen JE Antiviral Res; 1995 Sep; 28(1):81-91. PubMed ID: 8585762 [TBL] [Abstract][Full Text] [Related]
44. Amphiregulin anti-sense oligodeoxynucleotides inhibit growth and transformation of a human colon carcinoma cell line. Normanno N; Selvam MP; Bianco C; Damiano V; de Angelis E; Grassi M; Magliulo G; Tortora G; Salomon DS; Ciardiello F Int J Cancer; 1995 Sep; 62(6):762-6. PubMed ID: 7558427 [TBL] [Abstract][Full Text] [Related]
45. Inhibition of T4 polynucleotide kinase activity by phosphorothioate and chimeric oligodeoxynucleotides. Teasdale RM; Matson SJ; Fisher E; Krieg AM Antisense Res Dev; 1994; 4(4):295-7. PubMed ID: 7734945 [TBL] [Abstract][Full Text] [Related]
46. Growth factor-dependent inhibition of normal hematopoiesis by N-ras antisense oligodeoxynucleotides. Skorski T; Szczylik C; Ratajczak MZ; Malaguarnera L; Gewirtz AM; Calabretta B J Exp Med; 1992 Mar; 175(3):743-50. PubMed ID: 1371302 [TBL] [Abstract][Full Text] [Related]
47. Effects of phosphorothioated neuropeptide Y Y1-receptor antisense oligodeoxynucleotide in conscious rats and in human vessels. Sun XY; Zhao XH; Erlinge D; Edvinsson L; Fallgren B; Wahlestedt C; Hedner T Br J Pharmacol; 1996 May; 118(1):131-6. PubMed ID: 8733585 [TBL] [Abstract][Full Text] [Related]
48. Liposomal delivery of oligodeoxynucleotides. Tari A; Khodadadian M; Ellerson D; Deisseroth A; Lopez-Berestein G Leuk Lymphoma; 1996 Mar; 21(1-2):93-7. PubMed ID: 8907275 [TBL] [Abstract][Full Text] [Related]
49. Pseudo-cyclic oligonucleotides: in vitro and in vivo properties. Jiang Z; Kandimalla ER; Zhao Q; Shen LX; DeLuca A; Normano N; Ruskowski M; Agrawal S Bioorg Med Chem; 1999 Dec; 7(12):2727-35. PubMed ID: 10658577 [TBL] [Abstract][Full Text] [Related]
50. Contribution of sequence and phosphorothioate content to inhibition of cell growth and adhesion caused by c-myc antisense oligomers. Chavany C; Connell Y; Neckers L Mol Pharmacol; 1995 Oct; 48(4):738-46. PubMed ID: 7476902 [TBL] [Abstract][Full Text] [Related]
51. Effects of phosphodiester and phosphorothioate antisense oligodeoxynucleotides on cell lines which overexpress c-myc: implications for the treatment of Burkitt's lymphoma. Williams SA; Gillan ER; Knoppel E; Buzby JS; Suen Y; Cairo MS Ann Oncol; 1997; 8 Suppl 1():25-30. PubMed ID: 9187425 [TBL] [Abstract][Full Text] [Related]
52. Oligodeoxynucleotides enhance lipopolysaccharide-stimulated synthesis of tumor necrosis factor: dependence on phosphorothioate modification and reversal by heparin. Hartmann G; Krug A; Waller-Fontaine K; Endres S Mol Med; 1996 Jul; 2(4):429-38. PubMed ID: 8827713 [TBL] [Abstract][Full Text] [Related]
53. Specific inhibition of influenza virus RNA polymerase and nucleoprotein genes expression by liposomally endocapsulated antisense phosphorothioate oligonucleotides: penetration and localization of oligonucleotides in clone 76 cells. Hatta T; Takai K; Nakada S; Yokota T; Takaku H Biochem Biophys Res Commun; 1997 Mar; 232(2):545-9. PubMed ID: 9125219 [TBL] [Abstract][Full Text] [Related]
54. The binding of anti-DNA antibodies to phosphorothioate oligonucleotides in a solid phase immunoassay. Pisetsky DS; Reich CF Mol Immunol; 1998 Dec; 35(18):1161-70. PubMed ID: 10199390 [TBL] [Abstract][Full Text] [Related]
55. Rational design and rapid screening of antisense oligonucleotides for prokaryotic gene modulation. Shao Y; Wu Y; Chan CY; McDonough K; Ding Y Nucleic Acids Res; 2006; 34(19):5660-9. PubMed ID: 17038332 [TBL] [Abstract][Full Text] [Related]
56. Antisense phosphorothioate oligonucleotide inhibits interleukin 1 beta production in the human macrophage-like cell line, U937. Yahata N; Kawai S; Higaki M; Mizushima Y Antisense Nucleic Acid Drug Dev; 1996; 6(1):55-61. PubMed ID: 8783796 [TBL] [Abstract][Full Text] [Related]
57. Potent growth inhibition of leukemic cells by novel ribbon-type antisense oligonucleotides to c-myb1. Moon IJ; Choi K; Choi YK; Kim JE; Lee Y; Schreiber AD; Park JG J Biol Chem; 2000 Feb; 275(7):4647-53. PubMed ID: 10671493 [TBL] [Abstract][Full Text] [Related]